Legend Biotech Corp (LEGN) Receivables - Other (2019 - 2024)
Legend Biotech (LEGN) has disclosed Receivables - Other for 6 consecutive years, with $780000.0 as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Receivables - Other fell 1.27% year-over-year to $780000.0, compared with a TTM value of $780000.0 through Dec 2024, down 1.27%, and an annual FY2024 reading of $780000.0, down 1.27% over the prior year.
- Receivables - Other was $780000.0 for Q4 2024 at Legend Biotech, down from $790000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $790000.0 in Q4 2023 and bottomed at $262000.0 in Q4 2021.
- Average Receivables - Other over 5 years is $558200.0, with a median of $619000.0 recorded in 2020.
- The sharpest move saw Receivables - Other soared 2995.0% in 2020, then crashed 57.67% in 2021.
- Year by year, Receivables - Other stood at $619000.0 in 2020, then plummeted by 57.67% to $262000.0 in 2021, then increased by 29.77% to $340000.0 in 2022, then surged by 132.35% to $790000.0 in 2023, then fell by 1.27% to $780000.0 in 2024.
- Business Quant data shows Receivables - Other for LEGN at $780000.0 in Q4 2024, $790000.0 in Q4 2023, and $340000.0 in Q4 2022.